See more : Heron Therapeutics, Inc. (HRTX) Income Statement Analysis – Financial Results
Complete financial analysis of Lux Health Tech Acquisition Corp. (LUXA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lux Health Tech Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Charles River Laboratories International, Inc. (CRL) Income Statement Analysis – Financial Results
- XTGLOBAL INFOTECH LIMITED (XTGLOBAL.BO) Income Statement Analysis – Financial Results
- Better World Acquisition Corp. (BWACU) Income Statement Analysis – Financial Results
- Sinopec Kantons Holdings Limited (SPKOY) Income Statement Analysis – Financial Results
- Galenica AG (0ROG.L) Income Statement Analysis – Financial Results
Lux Health Tech Acquisition Corp. (LUXA)
Industry: Shell Companies
Sector: Financial Services
Website: https://www.luxcapital.com/companies/lux-health-tech-acquisition-corp/
About Lux Health Tech Acquisition Corp.
Lux Health Tech Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the healthcare and technology industries. The company was incorporated in 2020 and is based in New York, New York.
| Metric | 2021 | 2020 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 978.76K | 183.04K |
| Selling & Marketing | 0.00 | 0.00 |
| SG&A | 978.76K | 183.04K |
| Other Expenses | 0.00 | 0.00 |
| Operating Expenses | 978.76K | 183.04K |
| Cost & Expenses | 978.76K | 183.04K |
| Interest Income | 0.00 | 0.00 |
| Interest Expense | -28.28M | 0.00 |
| Depreciation & Amortization | 28.28M | 3.57K |
| EBITDA | 27.10M | -244.72K |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -1.18M | -248.30K |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | 28.28M | 3.57K |
| Income Before Tax | 27.10M | -244.72K |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | -28.28M | 0.00 |
| Net Income | 55.38M | -244.72K |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | 1.28 | -0.01 |
| EPS Diluted | 1.28 | -0.01 |
| Weighted Avg Shares Out | 43.12M | 43.12M |
| Weighted Avg Shares Out (Dil) | 43.12M | 43.12M |
Lux Health Tech Acquisition Corp. Announces Cancellation of Special Meeting of Stockholders and Liquidation
Lux Health Tech Acquisition Corp. Signs Letter of Intent for a Business Combination
Source: https://incomestatements.info
Category: Stock Reports